Vicks Vaporub
Pricing Report NDC 37000-544-03

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Vicks Vaporub (NDC 37000-544-03) is $0.06172 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 17, 2016.

As a provided by The Procter & Gamble Manufacturing Company, this medication is distributed in a 1 JAR in 1 CARTON / 100 g in 1 JAR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.06172
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Feb 17, 2016
Data Status
As of Mar 30, 2016
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
37000-544-03
Description
1 JAR in 1 CARTON / 100 g in 1 JAR
Generic Benchmark
The generic equivalent rate is $0.02163 (Effective: Mar 23, 2016)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.06172 to $0.06484 per GM. Over this 2 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0617 - $0.0648
Market Volatility
5.06% Variance
Latest Trend
4.81%
Date Unit Price Unit Source Method Rate
Feb 17, 2016 $0.06172 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Feb 17, 2016 $0.06172 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Dec 23, 2015 $0.06484 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Dec 23, 2015 $0.06484 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Nov 02, 2015 $0.06271 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Nov 02, 2015 $0.06271 GMC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Mar 18, 2015 $0.06281 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2015 $0.06281 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 18, 2015 $0.06281 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 18, 2015 $0.06281 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 18, 2015 $0.06281 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Feb 18, 2015 $0.06277 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Dec 18, 2013 $0.06289 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Dec 18, 2013 $0.06289 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Dec 18, 2013 $0.06289 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Nov 21, 2013 $0.06333 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026